Autoimmune Encephalitis Diagnostics and Treatment

Autoimmune encephalitis encompasses a group of inflammatory disorders in which pathogenic autoantibodies target neuronal cell-surface or synaptic proteins, leading to subacute cognitive impairment, seizures, movement disorders and psychiatric disturbances. Diagnosis rests on a combination of clinical assessment, neuroimaging, cerebrospinal fluid (CSF) analysis and the detection of specific neural autoantibodies by cell- or tissue-based assays. Magnetic resonance imaging often reveals limbic or extralimbic signal abnormalities, while CSF findings such as pleocytosis or oligoclonal bands support an inflammatory aetiology. Early identification of “red flags”—including rapid onset of cognitive decline, seizures refractory to conventional antiepileptics or autonomic instability—optimises the likelihood of initiating immunotherapy without unnecessary delays. First-line treatment typically comprises high-dose corticosteroids, intravenous immunoglobulin or plasma exchange, followed by second-line agents such as rituximab or cyclophosphamide in refractory cases. Tumour screening and removal are integral when a paraneoplastic trigger is identified. Prompt and appropriately tailored immunotherapy has been shown to improve long-term functional outcomes and reduce relapse rates, emphasising the global importance of standardised diagnostic criteria and treatment algorithms in both specialist and general clinical settings.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Autoimmune Encephalitis Diagnostics and Treatment publication trend

The graph below shows the total number of articles in autoimmune encephalitis diagnostics and treatment across all publications each year (not limited to Nature Index journals).

Technical terms

Autoantibody: an antibody produced by the immune system that erroneously recognises and binds to endogenous neural proteins, contributing to inflammation and neuronal dysfunction.

Cerebrospinal fluid pleocytosis: an increased white blood cell count in the CSF, indicative of central nervous system inflammation.

Immunotherapy: medical treatment aimed at modulating or suppressing aberrant immune responses, commonly employing corticosteroids, intravenous immunoglobulin or B-cell-targeted biological agents.

References

1. Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurology (2023).
2. Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis. American Journal of Neuroradiology (2017).
3. Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric Patients. Frontiers in Psychiatry (2017).
4. Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis—A Systematic Analysis. Frontiers in Neurology (2019).
5. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis. JAMA Neurology (2021).